RPS2P28: A Drug Target / Disease Biomarker (G100132673)

Target Name: RPS2P28

NCBI ID: G100132673

RPS2P28

Other Name(s): RPS2_13_694 | ribosomal protein S2 pseudogene 28 | Ribosomal protein S2 pseudogene 28

RPS2P28: A Drug Target / Disease Biomarker

RPScH4 (Resorinyl Pyruvate Carboxylic Acid) is a protein that is expressed in various tissues of the body, including the brain, muscle, and heart. It is a key regulator of the cellular response to stress, and has been implicated in a number of diseases, including neurodegenerative disorders, cancer, and cardiovascular disease.

One of the unique features of RPScH4 is its ability to interact with a variety of different molecules in the cell. This makes it an attractive target for researchers looking for new drugs or biomarkers.

In recent years, a number of studies have identified potential RPScH4 interactors, or drugs that may interact with the protein in order to modulate its activity. One of the most promising of these drugs is JNJ-752602, a small molecule inhibitor of RPScH4 that is currently being tested in clinical trials for the treatment of neurodegenerative disorders.

In addition to its potential as a drug, RPScH4 is also a valuable biomarker for a number of different diseases. For example, it has been shown to be elevated in the brains of individuals with Alzheimer's disease, and may be a useful diagnostic tool for this disease. Additionally, RPScH4 has been shown to be decreased in the hearts of individuals with heart failure, which may be a useful biomarker for this condition.

RPScH4 is also involved in a number of different cellular processes that are important for the proper functioning of the body. For example, it is involved in the regulation of cell death, as well as the regulation of cell growth and division. It is also involved in the regulation of the immune response, which is important for the fight against infection and disease.

In conclusion, RPScH4 is a protein that is expressed in various tissues of the body, and has been implicated in a number of different diseases. Its unique ability to interact with a variety of different molecules makes it an attractive target for researchers looking for new drugs or biomarkers. The identification of potential RPScH4 interactors, such as JNJ-752602, is promising for the development of new treatments for a variety of neurodegenerative disorders. Additionally, RPScH4 may also be a valuable biomarker for a number of different diseases, including Alzheimer's and heart failure. Further research is needed to fully understand the role of RPScH4 in the body and its potential as a drug or biomarker.

Protein Name: Ribosomal Protein S2 Pseudogene 28

The "RPS2P28 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS2P28 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets